Wendall Wierenga, Director at CYTOKINETICS INC (CYTK), sold 20,000 shares at $38.46 ($769K) on 2025-04-21, disclosed to the SEC on 2025-04-21.
Scheduled sale ($769k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |
| CYTK | SELL | 2023-08-21 | $386K | — | Filing → |